Who owns GW Pharmaceuticals?
Who owns GW Pharmaceuticals?
Jazz Pharmaceuticals
GW Pharmaceuticals/Parent organizations
Where is GW Pharmaceuticals located?
Cambridge, United Kingdom
GW Pharmaceuticals
| Type | Subsidiary |
|---|---|
| Headquarters | Cambridge, United Kingdom |
| Key people | Justin Gover (CEO) |
| Products | Epidiolex (Epidyolex in Europe) Nabiximols (Sativex) |
| Revenue | $527 million (2020) |
What happened to GW Pharmaceuticals?
Jazz Pharmaceuticals (NASDAQ:JAZZ) has officially closed its $7.2B acquisition of GW Pharmaceuticals plc (NASDAQ:GWPH). With the acquisition, Jazz gains access to GW’s cannabinoid portfolio, including Epidiolex, which raked in $510.5M in sales in 2020. …
When was GW Pharmaceuticals founded?
1998
GW Pharmaceuticals/Founded
Is Jazz Pharmaceuticals an American company?
Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is a biopharmaceutical company based in Ireland. It was founded in 2003….Jazz Pharmaceuticals.
| Type | Public company |
|---|---|
| Founded | March 2005 in California, U.S. |
| Headquarters | Waterloo Exchange, Waterloo Road, D04 E5W7, Dublin, Ireland |
| Area served | Worldwide |
Is Jazz Pharma a good company?
Jazz has been a good company overall with great benefits and great people. A typical day at work is always busy but productive. I learned a lot involving time management and effective routing due to having one of the largest territories in our region.
Where Is Jazz Pharma based?
Dublin, Ireland
Our corporate headquarters are located in Dublin, Ireland. In the North America, we have offices in Palo Alto and Carlsbad, California; Philadelphia, Pennsylvania; Vancouver, British Columbia; and Mississauga, Ontario.
Who is Otsuka Pharmaceutical?
Otsuka Pharmaceutical Co., Ltd. Helping to cure disease and protect everyday health. Otsuka Pharmaceutical is a holistic healthcare company dedicated to the entire body. By choosing to tackle unaddressed medical needs, we put ourselves on the path to creating new therapeutic approaches and unprecedented drugs.
What does the end of the GW-Otsuka deal mean for Sativex?
With the agreement terminated, GW regains full ownership of its drug in the U.S. — yet will still have to make contingent milestone payments to Otsuka if Sativex gains Food and Drug Administration approval or hits certain annual sales marks in the states.
What’s happened to GW Pharmaceuticals’ Sativex franchise?
GW Pharmaceuticals plc suffered another setback to its Sativex franchise on Wednesday, announcing that long-time partner Otsuka Pharmaceutical Co. Ltd. has decided to hand back rights to the cannabindoid drug.
Who is opotsuka pharmaceutical?
Otsuka Pharmaceutical is a holistic healthcare company dedicated to the entire body. By choosing to tackle unaddressed medical needs, we put ourselves on the path to creating new therapeutic approaches and unprecedented drugs.
